Carbohydrate based meningococcal vaccines: past and present overview
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbohydrate based meningococcal vaccines: past and present overview
Authors
Keywords
-
Journal
GLYCOCONJUGATE JOURNAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-27
DOI
10.1007/s10719-021-09990-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
- (2020) Jacopo Enotarpi et al. Nature Communications
- Structural and mechanistic basis of capsule O-acetylation in Neisseria meningitidis serogroup A
- (2020) Timm Fiebig et al. Nature Communications
- GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
- (2020) Francesca Micoli et al. Vaccines
- Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein
- (2019) Lingling Xu et al. VACCINE
- Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence
- (2019) Jamie Findlow et al. Future Microbiology
- Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup C
- (2019) Juned Dalal et al. VACCINE
- The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
- (2019) Vega Masignani et al. Frontiers in Immunology
- Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine Antigens
- (2018) Davide Oldrini et al. ACS Chemical Biology
- Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
- (2018) Francesca Micoli et al. MOLECULES
- Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy
- (2018) Patrizio Pezzotti et al. VACCINE
- Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study
- (2018) Jo Anne Welsch et al. VACCINE
- Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production
- (2017) Timm Fiebig et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative
- (2017) Ray Borrow et al. JOURNAL OF INFECTION
- Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data
- (2017) Caroline L Trotter et al. LANCET INFECTIOUS DISEASES
- High-yield production of recombinant CRM197, a non-toxic mutant of diphtheria toxin, in the periplasm of Escherichia coli
- (2017) Philippe Goffin et al. Biotechnology Journal
- Synthesis and immunochemical evaluation of a novel Neisseria meningitidis serogroup A tetrasaccharide and its conjugate
- (2017) Kishore R. Harale et al. Organic Chemistry Frontiers
- Preclinical studies on new proteins as carrier for glycoconjugate vaccines
- (2016) M. Tontini et al. VACCINE
- Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis
- (2016) Guochao Liao et al. ACS Central Science
- An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate
- (2016) Timm Fiebig et al. npj Vaccines
- Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines
- (2015) Guochao Liao et al. CHEMICAL COMMUNICATIONS
- Neisseria meningitidis: pathogenesis and immunity
- (2015) Mariagrazia Pizza et al. CURRENT OPINION IN MICROBIOLOGY
- Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus toxoid conjugate vaccine: Systematic review and meta-analysis
- (2015) Paolo Pellegrino et al. PHARMACOLOGICAL RESEARCH
- A Synthetic Disaccharide Analogue from Neisseria meningitidis A Capsular Polysaccharide Stimulates Immune Cell Responses and Induces Immunoglobulin G (IgG) Production in Mice When Protein-Conjugated
- (2015) Silvia Fallarini et al. ACS Infectious Diseases
- Synthesis and immunological evaluation of protein conjugates ofNeisseria meningitidisX capsular polysaccharide fragments
- (2014) Laura Morelli et al. Beilstein Journal of Organic Chemistry
- Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease
- (2014) Roberto Adamo et al. GLYCOCONJUGATE JOURNAL
- Molecular Cloning and Functional Characterization of Components of the Capsule Biosynthesis Complex ofNeisseria meningitidisSerogroup A
- (2014) Timm Fiebig et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunoactivity of Protein Conjugates of Carba Analogues from Neisseria meningitidis A Capsular Polysaccharide
- (2013) Qi Gao et al. ACS Chemical Biology
- Synthesis ofNeisseria meningitidisSerogroup W135 Capsular Oligosaccharides for Immunogenicity Comparison and Vaccine Development
- (2013) Chia-Hung Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: A new perspective for vaccine development
- (2013) T. Fiebig et al. GLYCOBIOLOGY
- Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates
- (2013) Pumtiwitt C. McCarthy et al. GLYCOCONJUGATE JOURNAL
- Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
- (2013) F. Micoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines
- (2013) M. Tontini et al. VACCINE
- Synthesis and preliminary biological evaluation of carba analogues from Neisseria meningitidis A capsular polysaccharide
- (2012) Qi Gao et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Relative stability of meningococcal serogroup A and X polysaccharides
- (2012) F. Berti et al. VACCINE
- History of meningococcal vaccines and their serological correlates of protection
- (2012) Caroline Vipond et al. VACCINE
- Development of a group A meningococcal conjugate vaccine,MenAfriVacTM
- (2012) Carl Frasch et al. Human Vaccines & Immunotherapeutics
- Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications
- (2011) Michael Bröker et al. BIOLOGICALS
- The design of semi-synthetic and synthetic glycoconjugate vaccines
- (2011) Paolo Costantino et al. Expert Opinion on Drug Discovery
- Highly Alpha-Selective Sialyl Phosphate Donors for Efficient Preparation of Natural Sialosides
- (2010) Che-Hsiung Hsu et al. CHEMISTRY-A EUROPEAN JOURNAL
- Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group B
- (2010) Becca A. Flitter et al. VACCINE
- Vaccine development against Neisseria meningitidis
- (2010) Ulrich Vogel et al. Microbial Biotechnology
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
- (2009) Caroline L Trotter et al. Expert Review of Vaccines
- Genotypic Comparison of Invasive Neisseria meningitidis Serogroup Y Isolates from the United States, South Africa, and Israel, Isolated from 1999 through 2002
- (2009) A. M. Whitney et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Vaccines Containing de- N -Acetyl Sialic Acid Elicit Antibodies Protective against Neisseria meningitidis Groups B and C
- (2009) Gregory R. Moe et al. JOURNAL OF IMMUNOLOGY
- Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
- (2009) Michael Bröker et al. VACCINE
- Meningococcal protein antigens and vaccines
- (2009) Ian M. Feavers et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
- (2008) D Pace et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases
- (2008) Angela Bardotti et al. VACCINE
- Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
- (2008) Che-Hung Lee et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started